Publicaciones (41) Publicaciones de MARÍA ERCIBENGOA ARANA

2024

  1. Author Correction: Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia (Scientific Reports, (2023), 13, 1, (17724), 10.1038/s41598-023-45007-4)

    Scientific Reports

2023

  1. Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022

    Frontiers in Public Health, Vol. 11

  2. Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia

    Scientific Reports, Vol. 13, Núm. 1

  3. MALDI-TOF MS as a tick identification tool in a tertiary hospital in Spain

    Acta Tropica, Vol. 242

  4. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

  5. Validation of an expanded, in-house library and an optimized preparation method for the identification of fungal isolates using MALDI-TOF mass spectrometry

    Medical mycology, Vol. 61, Núm. 4

2022

  1. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  2. Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398

2021

  1. Assessment of the optochin susceptibility test to differentiate streptococcus pneumoniae from other viridans group streptococci

    Clinical Laboratory, Vol. 67, Núm. 3, pp. 857-861

  2. Comparison of four methods for streptococcus pneumoniae capsular typing

    Clinical Laboratory, Vol. 67, Núm. 7, pp. 1598-1602

  3. The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 6, pp. 1075-1085

2020

  1. A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016

    International Journal of Infectious Diseases, Vol. 90, pp. 161-166

  2. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 6, pp. 753-759

  3. Genomic virulence features of two novel species nocardia Barduliensis sp. nov. and nocardia Gipuzkoensis sp. nov., isolated from patients with chronic pulmonary diseases

    Microorganisms, Vol. 8, Núm. 10, pp. 1-20

2019

  1. Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis

    BMC Infectious Diseases, Vol. 19, Núm. 1

  2. Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping

    PLoS ONE, Vol. 14, Núm. 2

  3. Variants of the bile: Solubility test to differentiate Streptococcus pneumoniae from other viridans group streptococci

    Future Microbiology, Vol. 14, Núm. 11, pp. 949-955

2018

  1. Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain

    PLoS ONE, Vol. 13, Núm. 12

  2. Future Applications of MALDI-TOF Mass Spectrometry in Clinical Microbiology

    The Use of Mass Spectrometry Technology (MALDI-TOF) in Clinical Microbiology (Elsevier), pp. 255-263

  3. Measuring Bacterial Glycosyl Hydrolase Activity with a Soluble Capture Probe by Mass Spectrometry

    Analytical Chemistry, Vol. 90, Núm. 21, pp. 12536-12543